» Articles » PMID: 10596008

Effect of Variation in the Common "a" Determinant on the Antigenicity of Hepatitis B Surface Antigen

Overview
Journal J Med Virol
Specialty Microbiology
Date 1999 Dec 14
PMID 10596008
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Antibody to the common "a" determinant of hepatitis B surface antigen (HBsAg) protects against infection with hepatitis B virus. A number of variant surface antigens with amino acid substitutions within the "a" determinant have been described in patients around the world. Both wild type and variant HBsAgs were expressed in the yeast Pichia pastoris and the antigens were semi-purified and quantitated. The effect on antigenicity of these changes was investigated in a quantitative fashion using four monoclonal antibodies known to bind to different epitopes within the common "a" determinant. The results suggest that amino acid substitution of T131I, K141E and G145R and insertion of 3 amino acids between residues 123 and 124 markedly affect the antigenic structure of HBsAg. These substitutions and insertions in the viral envelope may lead to evasion of the virus neutralizing antibody response and also to reduce efficiency of detection by immunoassays used for diagnosis and blood-bank screening.

Citing Articles

In vitro and in silico analyses of amino acid substitution effects at the conserved N-linked glycosylation site in hepatitis B virus surface protein on antigenicity, immunogenicity, HBV replication and secretion.

Tepjanta P, Saethang T, Fujiyama K, Misaki R, Kimkong I PLoS One. 2025; 20(1):e0316328.

PMID: 39761288 PMC: 11703054. DOI: 10.1371/journal.pone.0316328.


A Novel Insertion in the Hepatitis B Virus Surface Protein Leading to Hyperglycosylation Causes Diagnostic and Immune Escape.

Lehmann F, Slanina H, Roderfeld M, Roeb E, Trebicka J, Ziebuhr J Viruses. 2023; 15(4).

PMID: 37112819 PMC: 10144012. DOI: 10.3390/v15040838.


Analysis of the Physicochemical Properties, Replication and Pathophysiology of a Massively Glycosylated Hepatitis B Virus HBsAg Escape Mutant.

Hossain M, Suwanmanee Y, Du K, Ueda K Viruses. 2021; 13(11).

PMID: 34835134 PMC: 8622389. DOI: 10.3390/v13112328.


In silico analysis of mutations associated with occult hepatitis B virus (HBV) infection in South Africa.

Olagbenro M, Anderson M, Gaseitsiwe S, Powell E, Gededzha M, Selabe S Arch Virol. 2021; 166(11):3075-3084.

PMID: 34468889 DOI: 10.1007/s00705-021-05196-7.


A recombinant human immunoglobulin with coherent avidity to hepatitis B virus surface antigens of various viral genotypes and clinical mutants.

Jeong G, Ahn B, Jung J, Kim H, Kim T, Kim W PLoS One. 2020; 15(8):e0236704.

PMID: 32790777 PMC: 7425877. DOI: 10.1371/journal.pone.0236704.